These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30566110)

  • 1. The art of delivering evidence-based dual antiplatelet therapy.
    Curry WJ; Chambers CE; Curry GW; Curry EW
    J Fam Pract; 2018 Dec; 67(12):758-766. PubMed ID: 30566110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    ; Bittl JA; Baber U; Bradley SM; Wijeysundera DN
    Circulation; 2016 Sep; 134(10):e156-78. PubMed ID: 27026019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges of antiplatelet therapy in patients who require anticoagulation.
    Henkel DM; Holmes DR
    J Invasive Cardiol; 2009 Apr; 21(4):186-9. PubMed ID: 19342758
    [No Abstract]   [Full Text] [Related]  

  • 4. [Oral anticoagulants in elderly patients with coronary artery disease and atrial fibrillation].
    Gallet R; Teiger E
    Ann Cardiol Angeiol (Paris); 2018 Dec; 67(6):404-410. PubMed ID: 30342831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing antithrombotic therapy in patients with both atrial fibrillation and coronary heart disease.
    Thompson PL; Verheugt FW
    Clin Ther; 2014 Sep; 36(9):1176-81. PubMed ID: 25234549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimum Antithrombotic Therapy in Patients Requiring Long-Term Anticoagulation and Undergoing Percutaneous Coronary Intervention.
    Agarwal N; Mahtta D; Rambarat CA; Elgendy I; Mahmoud AN
    Biomed Res Int; 2018; 2018():5690640. PubMed ID: 29770334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.
    Valgimigli M; Bueno H; Byrne RA; Collet JP; Costa F; Jeppsson A; Jüni P; Kastrati A; Kolh P; Mauri L; Montalescot G; Neumann FJ; Petricevic M; Roffi M; Steg PG; Windecker S; Zamorano JL; Levine GN;
    Eur J Cardiothorac Surg; 2018 Jan; 53(1):34-78. PubMed ID: 29045581
    [No Abstract]   [Full Text] [Related]  

  • 8. Duration of Dual Antiplatelet Therapy in Coronary Artery Disease: a Review Article.
    Moseley AD; Collado FM; Volgman AS; Schaer GL; Snell RJ
    Curr Atheroscler Rep; 2016 Jul; 18(7):45. PubMed ID: 27260146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS.].
    Valgimigli M; Bueno H; Byrne RA; Collet JP; Costa F; Jeppsson A; Jüni P; Kastrati A; Kolh P; Mauri L; Montalescot G; Neumann FJ; Peticevic M; Roffi M; Steg PG; Windecker S; Zamorano JL
    Kardiol Pol; 2017; 75(12):1217-1299. PubMed ID: 29251754
    [No Abstract]   [Full Text] [Related]  

  • 10. Combining antiplatelet and anticoagulant therapies.
    Holmes DR; Kereiakes DJ; Kleiman NS; Moliterno DJ; Patti G; Grines CL
    J Am Coll Cardiol; 2009 Jul; 54(2):95-109. PubMed ID: 19573725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Dual antiplatelet therapy for treatment and secondary prevention of coronary artery disease: indications, modalities and duration].
    Degrauwe S; Iglesias JF
    Rev Med Suisse; 2016 May; 12(520):1022-6, 1028-34. PubMed ID: 27424342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulation and antiplatelet therapy in stable coronary artery disease: A multicenter survey.
    Kopin D; Jones WS; Klein A; Barnes GD
    Thromb Res; 2019 Aug; 180():25-27. PubMed ID: 31170568
    [No Abstract]   [Full Text] [Related]  

  • 13. Outcomes associated with combined antiplatelet and anticoagulant therapy.
    Johnson SG; Rogers K; Delate T; Witt DM
    Chest; 2008 Apr; 133(4):948-54. PubMed ID: 18198244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New oral anticoagulants and dual antiplatelet therapy: Focus on apixaban.
    Pelliccia F; Rollini F; Marazzi G; Greco C; Gaudio C; Angiolillo DJ; Rosano G
    Int J Cardiol; 2016 Dec; 225():154-158. PubMed ID: 27723533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential role of oral anticoagulants in the treatment of patients with coronary artery disease: focus on dabigatran.
    Doraiswamy VA; Slepian MJ; Gesheff MG; Tantry US; Gurbel PA
    Expert Rev Cardiovasc Ther; 2013 Sep; 11(9):1259-67. PubMed ID: 23968500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention.
    Majithia A; Bhatt DL
    Interv Cardiol Clin; 2017 Jan; 6(1):25-37. PubMed ID: 27886820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the Treatment of Stable Coronary Artery Disease and Peripheral Artery Disease.
    Gibler WB
    Crit Pathw Cardiol; 2018 Jun; 17(2):53-68. PubMed ID: 29768312
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of Different β-Blockers on Platelet Aggregation in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy.
    Ignjatovic V; Pavlovic S; Miloradovic V; Andjelkovic N; Davidovic G; Djurdjevic P; Stolic R; Iric-Cupic V; Simic I; Ignjatovic VD; Petrovic N; Smiljanic Z; Zdravkovic V; Simovic S; Jovanovic D; Nesic J
    J Cardiovasc Pharmacol Ther; 2016 Jan; 21(1):44-52. PubMed ID: 25868659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Bittl JA; Baber U; Bradley SM; Wijeysundera DN
    J Am Coll Cardiol; 2016 Sep; 68(10):1116-39. PubMed ID: 27036919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mean platelet volume and high-residual platelet reactivity in patients receiving dual antiplatelet therapy with clopidogrel or ticagrelor.
    Verdoia M; Pergolini P; Rolla R; Nardin M; Barbieri L; Schaffer A; Bellomo G; Marino P; Suryapranata H; De Luca G
    Expert Opin Pharmacother; 2015; 16(12):1739-47. PubMed ID: 26067422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.